Fluticasone Furoate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

39 API Suppliers, 15 USDMF, 5 CEP/COS, 3 JDMF, 5 EU WC, 2 KDMF, 19 NDC API, 22 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

28 Drugs in Development

28 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

132 FDF Dossiers, 9 FDA Orange Book, 100 Europe, 7 Canada, 4 Australia, 7 South Africa, 5 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INHALATION - 0.05MG/INH;EQ 0.025MG BASE/INH, POWDER;INHALATION - 0.1MG/INH;EQ 0.025MG BASE/INH, POWDER;INHALATION - 0.2MG/INH;EQ 0.025MG BASE/INH, POWDER;INHALATION - 0.05MG/INH, POWDER;INHALATION - 0.1MG/INH, POWDER;INHALATION - 0.2MG/INH, SPRAY, METERED;NASAL - 0.0275MG/SPRAY

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 1 SPI Pharma, 2 DKSH, 3 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 3 Kirsch Pharma, 4 Actylis, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 1 BASF, 4 DFE Pharma, 1 Finar, 6 Gangwal Chemicals, 1 Ideal Cures, 10 Kerry, 2 Keval Exports, 1 Kima Chemical, 12 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 2 Prachin Chemical, 7 Roquette, 6 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Sigachi Industries, 2 Silverline Chemicals, 1 The Dow Chemical Company, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

28 Fillers, Diluents & Binders, 19 Thickeners and Stabilizers, 15 Solubilizers, 13 Direct Compression, 11 Granulation, 10 Parenteral, 9 Lubricants & Glidants, 9 Co-Processed Excipients, 6 Rheology Modifiers, 5 Disintegrants & Superdisintegrants, 4 Emulsifying Agents, 4 Coating Systems & Additives, 4 Film Formers & Plasticizers, 3 Surfactant & Foaming Agents, 3 Topical, 3 Controlled & Modified Release, 3 Chewable & Orodispersible Aids, 2 Taste Masking, 1 API Stability Enhancers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 54 News #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 56 Regulatory FDF Prices, 42 Annual Reports

MARKET PLACE

6 APIs

6 APIs

PATENTS & EXCLUSIVITIES

73 US Patents, 5 US Exclusivities, 19 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 USP

4 USP

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 22051 / DOSAGE - SPRAY, METERED;NASAL - 0.0275MG/SPRAY

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
FLUTICASONE FUROATE(UNII: JS86977WNV) (FLUTICASONE - UNII:CUT2W21N7U)	FLUTICASONE FUROATE	27.5ug

Inactive Ingredients

Ingredient Name	GlaxoSmithKline LLC	Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC	REMEDYREPACK INC.
ANHYDROUS DEXTROSE(5SL0G7R0OK)
BENZALKONIUM CHLORIDE(F5UM2KM3W7)
CARBOXYMETHYLCELLULOSE SODIUM(K679OBS311)
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM(K679OBS311)
CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)
EDETATE DISODIUM(7FLD91C86K)
POLYSORBATE 80(6OZP39ZG8H)
WATER(059QF0KO0R)

Setid 4e444ce8 3dca 4a95 8ebf 752da67e80ff Applno 22051 Form Spray Metered Nasal Dosage 0 0275mg Spray - Drug Product Composition: Fluticasone Furoate